Corpus Intelligence Market Analysis — HOLY NAME HOSPITAL 2026-04-26 05:30 UTC
Market Analysis — HOLY NAME HOSPITAL
NJ market | 8 hospitals | HHI: 2,605 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
8
Hospitals in Market
2,044
Total Beds
$4.9B
Market Revenue
Concentrated
HHI: 2,605
Narrow
Moat Rating (6/10)
#4
Market Share Rank

Competitive Moat (Mauboussin Framework)

Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).

Scale Advantagemoderate
Switching Costshigh
Market Share10.2%
Top 3 Concentration80.7%
Network Density0.39
Margin vs Market+7.1%
Bed Util vs Market-10.5%

What This Means

This hospital has a narrow moat — narrow moat — some competitive advantages, but vulnerable to new entrants. The NJ market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 2,605).

Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full NJ market.

Top Competitors

HospitalBedsRevenueRev ShareBed Share
HACKENSACK UNIVERSITY MEDICAL CENTER779$1,996M41.1%38.1%
ENGLEWOOD HOSPITAL & MED CTR292$967M19.9%14.3%
THE VALLEY HOSPITAL385$952M19.6%18.8%
BERGEN NEW BRIDGE MEDICAL CENTER101$187M3.9%4.9%
HACKENSACK UMC AT PASCACK VALLEY78$149M3.1%3.8%
RAMAPO RIDGE PSYCHIATRIC58$78M1.6%2.8%
SSH - NORTHEAST NEW JERSEY INC.62$30M0.6%3.0%

Regional Payer Mix

■ Medicare 34%■ Medicaid 5%■ Commercial 61%